entinostat has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nidhyanandan, S | 1 |
| Boreddy, TS | 1 |
| Chandrasekhar, KB | 1 |
| Reddy, ND | 1 |
| Kulkarni, NM | 1 |
| Narayanan, S | 1 |
| Srivastava, RK | 1 |
| Kurzrock, R | 1 |
| Shankar, S | 1 |
2 other studies available for entinostat and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzami | 2015 |
MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo.
Topics: Animals; Apoptosis; Benzamides; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; D | 2010 |